Peroxisome Carrier SLC25A17: Potential Biomarker for Peroxisome Dysfunction and Human Disease

Area of Science:

• Cellular Biology
• Biochemistry
• Genetics

Background:

• Solute carrier family 25 (SLC25) proteins transport metabolites across organelle membranes.
• SLC25A17 is the sole SLC25 member in peroxisomes, previously known as PMP34.
• Its precise function is debated, with conflicting data on cofactor specificity and differing phenotypes across models.

Purpose of the Study:

• To review current knowledge on SLC25A17 functions.
• To highlight emerging roles of SLC25A17 in human diseases.
• To guide future research on its metabolic significance and disease pathogenesis.

Main Methods:

• Literature review of existing studies on SLC25A17.
• Analysis of experimental models (e.g., mice, zebrafish) and human disease data.
• Synthesis of information on SLC25A17 localization, function, and disease associations.

Main Results:

• SLC25A17 deficiency is linked to peroxisomal dysfunction.
• Altered SLC25A17 expression is observed in cancers and bipolar disorder.
• The molecular mechanisms underlying these associations remain largely unknown.

Conclusions:

• SLC25A17's role in peroxisomal transport and metabolism requires further elucidation.
• Understanding SLC25A17 is crucial for deciphering its involvement in various human diseases.
• Clarifying SLC25A17 function may reveal new therapeutic targets.